Olfr900 is an olfactory receptor gene found in Mus musculus (house mouse). It plays a crucial role in the perception of smells by interacting with odorant molecules in the nose. Olfr900 belongs to the family of G-protein-coupled receptors (GPCRs) that have a 7-transmembrane domain structure, similar to neurotransmitter and hormone receptors. These receptors are responsible for recognizing odorant signals and transmitting them through G protein-mediated transduction. The olfactory receptor gene family in mice is extensive and diverse, with each receptor having a specific function in detecting different odorants. Olfr900, like other olfactory receptors, contributes to the remarkable ability of mice to discriminate between a wide range of odors. The nomenclature for olfactory receptor genes and proteins in mice is unique to this species and is independent of other organisms.
Inhibiting Olfr900 can be challenging, given that olfactory receptors are part of a highly specialized system designed for odor detection. Direct inhibitors targeting olfactory receptors are not commonly known. However, one approach to potentially influence Olfr900 could involve modulating the signaling pathways associated with olfactory signal transduction. One such pathway is the cAMP (cyclic adenosine monophosphate) signaling pathway. Olfactory receptors like Olfr900 are known to activate this pathway upon binding to odorants. Therefore, chemicals that inhibit adenylyl cyclase, the enzyme responsible for cAMP production, may indirectly affect the signaling cascade initiated by Olfr900. By reducing cAMP levels, these inhibitors could potentially impair the transmission of olfactory signals, leading to a diminished perception of smells. Another indirect approach could involve targeting downstream components of the olfactory signaling pathway. For instance, inhibiting molecules involved in the activation of sensory neurons or the transmission of signals from olfactory receptors to the brain could disrupt the overall olfactory perception. These inhibitors would not directly interact with Olfr900 but could influence its function by blocking key intermediates in the signaling cascade.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3Ks), potentially affecting downstream signaling pathways related to Olfr900. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor that can modulate the MAPK pathway, which may indirectly influence Olfr900 regulation. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can influence calcium signaling pathways, potentially impacting Olfr900 function. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
This inhibitor targets glycogen synthase kinase-3 (GSK-3), which can influence various signaling pathways related to Olfr900. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a calcium chelator that can reduce intracellular calcium levels, potentially affecting Olfr900-related processes. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
PTX inhibits G protein signaling, which could indirectly influence Olfr900 activity through GPCR-related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin targets mTOR, a key protein in cellular processes, potentially affecting pathways associated with Olfr900. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580 inhibits p38 MAPK, a kinase involved in stress response pathways that may intersect with Olfr900 regulation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-glycosylation, which could indirectly impact Olfr900 by affecting protein maturation and trafficking. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A targets calcineurin and can influence calcium-dependent signaling, which may have downstream effects on Olfr900. | ||||||